Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

US measles outbreak worst for 15 years

February 11, 2015 Sales and Marketing FDA, cdcp, hamburg, measles, priorix, trimovax, vaccines

The worst measles outbreak in 15 years has reached a startling 121 cases in the US alone according to the …
News

GSK buys bacteria vaccine firm

February 11, 2015 Research and Development, Sales and Marketing EC, GSK, GlaxoSmithKline, GlycoVaxyn, Novartis, vaccines

GlaxoSmithKline is continuing the significant expansion of its vaccine business with the purchase of Swiss biopharma company GlycoVaxyn. The UK …
News

MRC Technology hires senior head from Shire

February 11, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Edward Bliss, MRC, Shire

UK medical research charity MRC Technology has appointed Dr Edward Bliss to the new role of general counsel and company …
Appointment

Pharma’s reputation ‘is worsening among patients’

February 10, 2015 Medical Communications, Research and Development, Sales and Marketing HIV, ViiV Healthcare, patientview, pharma, reputation, transparency

Only around four in ten patients believe pharma has a good reputation and many companies are failing to win patient …
News

Charity challenges Sovaldi patent

February 10, 2015 Sales and Marketing Gilead, HCV, Médecins du Monde, sofosbuvir, sovaldi, world health organization

Doctors of the World (also known as Médecins du Monde) has filed an opposition to the patent for Gilead’s blockbuster …
News

Gilead expands UK presence with new London HQ

February 10, 2015 Research and Development, Sales and Marketing Cambridge, Gilead, London, NICE, UK, johnson, medcity, sovaldi, uxbridge

Gilead is to create a new UK commercial secondary headquarters in central London doubling its UK workforce to 600 by …
News

Second late-stage COPD trial for GSK and Theravance

February 10, 2015 Sales and Marketing COPD, FF/UMEC/VI, GSK, Theravance, fluticasone furoate, umeclidinium, vilanterol

GlaxoSmithKline and Theravance have begun a second Phase III trial of their investigational triple combination COPD drug as the former …
News

Hospira recalls Propofol drug again

February 10, 2015 Manufacturing and Production, Sales and Marketing Hospira, Pfizer, diprivan, manufacturing, merger, propofol

Hospira has issued a recall of anaesthesia support drug Propofol after the neck of one vial was revealed to contain …
News

Pfizer replaces UK managing director

February 10, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Erik Nordkamp, Pfizer, jonathan emms

Erik Nordkamp has been named as the managing director of Pfizer UK to take over from Jonathan Emms. Emms has …
Appointment

MHRA shuts down unlicensed cancer drug facility

February 9, 2015 Manufacturing and Production, Sales and Marketing Cambridge, GcMAF, MHRA, first immune, globulin component macrophage activating factor

The MHRA has shut down an unlicensed Cambridgeshire plant that was producing a potentially dangerous drug to be sold online. …
News

New president for ABPI

February 9, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Amgen, Pfizer, Whitehead, emms, john kearney

The Association of the British Pharmaceutical Industry has appointed John Kearney as its new president. Stepping into the role in …
News

FDA clears Roche eye drug

February 9, 2015 Sales and Marketing AMD, DME, FDA, Lucentis, Retina, Roche, eyes, ranibizumab

The US Food and Drug Administration has shown Roche’s eye-condition drug Lucentis the green light to treat patients with diabetic …
News

Financial round-up: how has pharma fared in 2014?

February 9, 2015 Medical Communications, Research and Development, Sales and Marketing

A select look at the latest figures and performance from some of the industry’s big players:MerckQuarter four 2014 sales Sales of …
News

Centogene appoints chief business officer

February 9, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Péter Adorján, centogene

Dr Péter Adorján has been appointed to the board of German rare disease firm Centogene and thereby extending its board …
Appointment

Changing our minds about depression

February 9, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Campbell, Lamb, Lundbeck, depression, economist, mind

Alastair Campbell, former Labour spin doctor and depression patient, thinks that mental and physical health should not be seen as …
Feature
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026